References
- Monaco AP, Neve RL, Colletti-Feener C, Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986;323:646–50.
- Hoffman EP, Brown RH, Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919–28.
- Den Dunnen JT, Grootscholten PM, Dauwerse JG, Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet 1992;1:19–28.
- Oudet C, Hanauer A, Clemens P, Two hot spots of recombination in the DMD gene correlate with the deletion prone regions. Hum Mol Genet 1992;1:599–603.
- Lalic T, Vossen RH, Coffa J, Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet 2005;13:1231–1234.
- Skuk D, Goulet M, Roy B, Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006;65:371–86.
- Skuk D, Goulet M, Roy B, Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther: the journal of the American Society of Gene Therapy 2004;9:475–82.
- Takahashi K, Tanabe K, Ohnuki M, Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861–72.
- Park IH, Arora N, Huo H, Disease-specific induced pluripotent stem cells. Cell 2008;134:877–86.
- Kazuki Y, Hiratsuka M, Takiguchi M, Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol Ther 2009;18:386–93.
- Kumazaki T, Kurata S, Matsuo T, Establishment of human induced pluripotent stem cell lines from normal fibroblast TIG-1. Hum Cell 2011;24:96–103.
- Ou Z, Li S, Li Q, Duchenne muscular dystrophy in a female patient with a karyotype of 46,X,i(X)(q10). Tohoku J Exp Med 2010;222:149–153.
- Sun X, Long X, Yin Y, Similar biological characteristics of human embryonic stem cell lines with normal and abnormal karyotypes. Hum Reprod 2008;23:2185–2193.
- Yang J, Cai J, Zhang Y, Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J Biol Chem 2010;285:40303–11.
- Zhang J, Lian Q, Zhu G, A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2010;8:31–45.
- Mayshar Y, Ben-David U, Lavon N, Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010;7:521–31.
- Cai J, Li W, Su H, Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 2010;285:11227–34.
- Na J, Plews J, Li J, Molecular mechanisms of pluripotency and reprogramming. Stem Cell Res Ther 2010;1:33.
- Watanabe S, Hirai H, Asakura Y, MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells 2011; 29:505–16.
- Goudenege S, Lebel C, Huot NB, Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol Ther 2012;20:2153–67.
- Dimos J, Rodolfa K, Niakan K, Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218–21.
- Luo Y, Fan Y, Zhou B, Generation of induced pluripotent stem cells from skin fibroblasts of a patient with olivopontocerebellar atrophy. Tohoku J Exp Med 2012;226:151–9.
- Li W, Wang X, Fan W, Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Hum Mol Genet 2011;21:32–45.